Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Weetabix Cereal Sold to Post in £1.4 Billion Deal

XTALKS VITALS NEWS

Cereal

The cereal was sold by Shanghai-based Bright Food, which acquired a controlling stake in the company in 2012. Photo by freeimages.com/Adam Davis

Share this!

April 20, 2017 | by Sarah Hand, M.Sc.

US cereal brand Post Holdings has purchased the UK’s iconic Weetabix band in a deal worth £1.4 billion. The cereal was sold by Shanghai-based Bright Food, which acquired a controlling stake in the company in 2012.

Post is currently the third-largest cereal company in the US, specializing in other breakfast cereals including Honey Bunches of Oats and Grape-Nuts. Along it the popular breakfast cereal, the Weetabix portfolio includes Alpen muesli, Ready Brek, Barbara’s and Weetos.

Bright Food originally acquired Weetabix in the hopes that its popularity in China would grow over traditional Asian breakfast items. However, sales of Weetabix were insufficient to capture enough of the market share.

While sales of Weetabix remain highest in the UK, the breakfast cereal is exported to over 90 countries around the world. It is also primarily manufactured in the UK, with all of the wheat used in the product supplied by local farmers.



“We have long admired Weetabix as a leader in cereal and believe it will be a fantastic strategic fit within Post,” said Rob Vitale, Post’s President and CEO. “Combining together two category leaders continues our strategy of strengthening our portfolio in stable categories and diversifying into new markets, bringing much-loved brands to significantly more customers globally. We are excited about the growth opportunities that this acquisition brings.”

Weetabix employs around 1,800 people around the world, and CEO of the company Giles Turrell has already said that he doesn’t not expect there to be job cuts as a result of the transaction. “Post has no footprint or manufacturing in the UK,” said Turrell. “As long as we remain successful in the marketplace we will continue to manufacture at our plants here in Northamptonshire.”

Post’s annual revenues total $5 billion per year, with Weetabix bringing in £410 million in 2016. The deal is expected to be completed in the third quarter of 2017.


Keywords:  Food Industry, Food Manufacturing, Food Sales


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Canadian Regulator Recalls Pie Shells Over E. Coli Contaminated Flour

April 28, 2017 - Multiple brands of pie and tart shells are being recalled in Canada after the flour used to manufacture them was linked to 28 cases of illness due to infection with E. coli O121.

Featured In: Food News


FDA Sends Warning Letters to Manufacturers of Fake Cancer Drugs

April 27, 2017 - The FDA is cracking down on the sale of illegal cancer drugs by sending warning letters to 14 US companies selling the unapproved products.

Featured In: Life Science News, Drug Safety News


Womb-Like Device Could Increase Survival of Premature Babies

April 27, 2017 - Researchers at the Children's Hospital of Philadelphia (CHOP) have developed a womb-like device which mimics the environmental conditions found inside the uterus.

Featured In: Life Science News, Medical Device News

LEAVE A COMMENT
 
  
THE XTALKS VITALS LIFE SCIENCE BLOG

What Medical Device Manufacturers Need to Know Before Developing a Biological Safety Evaluation

REGISTER FOR THESE WEBINARS

Technology Solutions for Late Phase Research: Optimising Real World Data Assets


Serialization for Late Starters – With Live Industry Research Results


Clinical Not All Antioxidants Are Created Equal: Astaxanthin, The Antioxidant Powerhouse


The New Gold Standards of IRT Delivery for Clinical Trials


Copyright © 2016-2017 Honeycomb Worldwide Inc.